A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Clinical trial NCT02386111 · TERMINATED

Trial details

NCT number: NCT02386111
Sponsor: Celldex Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Kidney Diseases Kidney Neoplasms Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Neoplasms Neoplasms by Histologic Type Clear-cell Metastatic Renal Cell Carcinoma

Start date: 2015-05-01
Primary completion: 2017-08-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.